Liven Pharma Limited has announced the successful completion of its first export order to the Arab region, marking a milestone in the company’s efforts to expand its global footprint.
In a notice to the Pakistan Stock Exchange (PSX) on Thursday, the company said the order was originally received last year and fulfilled during the current year.
The development follows the firm’s recent announcement to raise Rs200 million through a rights issue aimed at strengthening its financial base and supporting growth initiatives. Under the plan, Liven Pharma will issue 20 million ordinary shares at Rs10 each — equivalent to about 21.5% of its paid-up capital. This represents 21.496 rights shares for every 100 ordinary shares held by shareholders at the close of the share transfer books.
Liven Pharma, incorporated in Pakistan on October 21, 1991 as a private limited company, was converted into a public limited company on April 30, 1992 under the Companies Ordinance, 1984 (now replaced by the Companies Act, 2017). Its principal business remains the manufacturing of pharmaceuticals and allied products.
